Lumentum Joins the S&P 500 Soon: Buy the Dip Before the Index Funds Have To?

"Our results continue to highlight the strength of our roadmaps for both optical components and systems, which make us mission-critical to the world's AI leaders. The optical circuit switch backlog exceeds $400 million, and co-packaged optics recently secured an incremental multi-hundred-million-dollar order deliverable in the first half of calendar 2027."

"Lumentum currently trades around $672, well off its 52-week high of $783.80. The stock is up 82.32% year-to-date, while the S&P 500 is down 0.82% over the same period. One valuation model pegs fair value at $853, implying roughly 21% upside from current levels."

"In Q2 FY26, Lumentum posted $665.5 million in revenue, up 65.5% year-over-year, with non-GAAP operating margin expanding 1,730 basis points to 25.2%. Q3 guidance calls for $780 million to $830 million in revenue, implying over 85% YoY growth."

"At a trailing P/E of roughly 196x, even believers must acknowledge the execution premium baked in. Insiders have been selling aggressively: $38.85 million in insider sales followed the post-earnings run-up, including CEO Michael Hurlston selling 20,169 shares."

Lumentum faces a pivotal moment with its S&P 500 inclusion effective March 23, 2026, creating date-certain buying obligations from passive index funds regardless of valuation. The company demonstrates strong operational momentum with Q2 FY26 revenue of $665.5 million, up 65.5% year-over-year, and non-GAAP operating margins expanding to 25.2%. Q3 guidance projects 85% year-over-year growth. Two major product lines drive future growth: optical circuit switches with over $400 million backlog and co-packaged optics with multi-hundred-million-dollar orders. Nvidia's $2 billion strategic investment and multibillion-dollar purchase commitment validate the company's mission-critical role in AI infrastructure. However, the trailing P/E of 196x reflects significant execution premium, and insider selling of $38.85 million raises concerns about management confidence at current valuations.

Read at 24/7 Wall St.